Status:
COMPLETED
Biomarker Database Registry for Photodynamic Therapy
Lead Sponsor:
The Cleveland Clinic
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research is to obtain a blood sample from patients with actinic keratoses undergoing routine Photodynamic Therapy, in order to measure biomarkers that are relevant to VitD and 5FU ...
Detailed Description
Patients who have been scheduled to receive PDT in our noninvasive cutaneous oncology clinics will be given written information prior to their visit, including a copy of the Informed Consent (IC) that...
Eligibility Criteria
Inclusion
- Males or females, at least 18 years of age
- Patient has nonhypertrophic actinic keratosis, at least 10 AK lesions present on the face, scalp, forearms, chest, or legs at the time of PDT treatment
Exclusion
- taking doxycline, a photosensitizer
- using topical retinoids, since these can exacerbate the post-PDT erythema reaction
- pregnant
Key Trial Info
Start Date :
October 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT03319251
Start Date
October 6 2017
End Date
October 31 2023
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195